December 2021

Gyani Inder Singh Institute of Professional Studies has set an excellent example of providing high quality Medical & Health Science in the finest possible educational environment at an affordable cost. This Institute is nurturing future citizens by training them and honing their skills.

Post : Librarian,  Lab Technician / Lab. Attendant

Ratnamani Healthcare Pvt. Ltd. is one of the youngest and most emerging pharmaceutical player in the export market. It's a successful bold endeavor of Mr.Jitendra Sanghvi - a young and energetic entrepreneur. Mr. Sanghvi hails from the promoter family of Ratnamani Metals and Tubes Ltd.  Ratanamani Healthcare a WHO GMP certified manufacturing facility, manufactures general therapeutic and antibiotic drugs, tablets, capsules, oral liquid, dry powder and effervescent powder.

In todays world, demand is rising rapidly. Healthcare needs are no exception, and are touching new heights every day. Pharmaceutical companies – pillars of the healthcare system – face multiple challenges of adhering to the imposed regulations, providing affordable generics to patients and maintaining a diverse portfolio with the constant pressure of the patent’s expiry.

Pulse is a fast-growing Pharmaceutical company with a vertically and diagonally integrated business model, focused on providing innovative product solutions to a large number of people around the world, to help them manage their health better & lead a quality life.

About Author
Dr. R. S. Thakur
Chief Editor
Journal of Pharmaceutical Research
Krupanidhi College of Pharmacy
Bengaluru-560035.
Email: drramsthakur@gmail.com

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 93rd Authority meeting dated 15.11.2021. The drug candidate Dapagliflozin and metformin extended release is included in 17 formulations out of 20 for which price fixation is applied. Dapagliflozin was patented by AstraZeneca and there are sixteen USA patents protecting this drug and one Paragraph IV challenge.

Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. This decision comes just hours after the recommendation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), reflecting the urgent need for Actemra/RoActemra as a potential treatment option during the COVID-19 public health emergency.

GlaxoSmithKline plc and Vir Biotechnology, Inc announced an update to preclinical data on bioRxiv1, a preprint server, demonstrating that sotrovimab, an investigational monoclonal antibody, retains in vitro activity against the full known Omicron spike protein, the new SARS-CoV-2 variant (B.1.1.529). The preclinical data was generated through pseudo-virus testing of the combined known mutations of the Omicron variant, which included the maximum number of changes (37 mutations) identified to date in the spike protein.

CSIR- Central Drug Research Institute (CSIR-CDRI), a premier drug research institute of India was inaugurated on 17th Feb 1951 by the then Prime Minister of India Pt. Jawaharlal Nehru with a vision to strengthen and advance the field of drug research and development in the country. The Institute has made significant accomplishments in the pursuit of its mission to New Drugs & Technologies for affordable healthcare for all, generation of knowledge base and nurturing future leaders for healthcare sector.